CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 237-243

  Xu, Wei ^a   Li, Jian Yong ^a   Wu, Yu Jie ^a   Yu, Hui ^a   Shen, Qiu Dan ^a   Tian, Tian ^a   Li, Li ^a   Qiu, Hong Xia ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CD38 expression; Chronic lymphocytic leukemia; Prognosis

Indexed keywords

BETA 2 MICROGLOBULIN; CD38 ANTIGEN; LACTATE DEHYDROGENASE; PROTEIN KINASE ZAP 70;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CHINESE; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 21;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; ASIAN CONTINENTAL ANCESTRY GROUP; BETA 2-MICROGLOBULIN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; FLOW CYTOMETRY; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 56949084035     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.026     Document Type: Article

References (30)

1. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., and Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 46 (1975) 219-234
2. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48 (1981) 198-206
3. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
4. Matrai Z., Lin K., Dennis M., Sherrington P., Zuzel M., Pettitt A.R., et al. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood 97 (2001) 1902-1903
5. Ibrahim S., Keating M., Do K.A., O'Brien S., Huh Y.O., Jilani I., et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98 (2001) 181-186
6. Del Poeta G., Maurillo L., Venditti A., Buccisano F., Epiceno A.M., Capelli G., et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 98 (2001) 2633-2639
7. Chevallier P., Penther D., Avet-Loiseau H., Robillard N., Ifrah N., Mahe B., et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 116 (2002) 142-150
8. Durig J., Naschar M., Schmucker U., Renzig-Kohler K., Holter T., Huttmann A., et al. CD38 expression is an important prognostic marker in chronic lymphocytic leukemia. Leukemia 16 (2002) 30-35
9. Jelinek D.F., Tschumper R.C., Geyer S.M., Bone N.D., Dewald G.W., Hanson C.A., et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 115 (2001) 854-861
10. Morabito F., Mangiola M., Oliva B., Stelitano C., Callea V., Deaglio S., et al. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia. Leuk Res 25 (2001) 927-932
11. D'Arena G., Musto P., Cascavilla N., Dell'Olio M., Di Renzo N., Perla G., et al. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 42 (2001) 109-114
12. Heintel D., Schwarzinger I., Chizzali-Bonfadin C., Thalhammer R., Schwarzmeier J., Fritzer-Szekeres M., et al. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia. Leuk Lymphoma 42 (2001) 1315-1321
13. Domingo-Domenech E., Domingo-Claros A., Gonzalez-Barca E., Beneitez D., Alonso E., Romagosa V., et al. CD38 expression in B-cell chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Haematologica 87 (2002) 1021-1027
14. Ghia P., Guida G., Stella S., Gottardi D., Geuna M., Strola G., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101 (2003) 1262-1269
15. Thornton P.D., Fernandez C., Giustolisi G.M., Morilla R., Atkinson S., A'Hern R.P., et al. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. Hematol 5 (2004) 145-151
16. Gentile M., Mauro F.R., Calabrese E., De Propris M.S., Giammartini E., Mancini F., et al. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol 130 (2005) 549-557
17. Boonstra J.G., van Lom K., Langerak A.W., Graveland W.J., Valk P.J., Kraan J., et al. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression. Cytometry B Clin Cytom 70 (2006) 136-141
18. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87 (1996) 4990-4997
19. Durig J., Nuckel H., Cremer M., Fuhrer A., Halfmeyer K., Fandrey J., et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 17 (2003) 2426-2434
20. Schroers R., Griesinger F., Trumper L., Haase D., Kulle B., Klein-Hitpass L., et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukaemia. Leukemia 19 (2005) 750-758
21. Xu W., Li J.Y., Pan J.L., Qiu H.R., Shen Y.F., Li L., et al. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. Int J Hematol 85 (2007) 430-436
22. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102 (1998) 1515-1525
23. Magnac C., Porcher R., Davi F., Nataf J., Payelle-Brogard B., Tang R.P., et al. Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL. Leukemia 17 (2003) 133-137
24. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
25. Lin K., Sherrington P.D., Dennis M., Matrai Z., Cawley J.C., and Pettitt A.R. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100 (2002) 1404-1409
26. Krober A., Seiler T., Benner A., Bullinger L., Bruckle E., Lichter P., et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100 (2002) 1410-1416
27. Hamblin T.J., Orchard J.A., Ibbotson R.E., Davis Z., Thomas P.W., Stevenson F.K., et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99 (2002) 1023-1029
28. Gachard N., Salviat A., Boutet C., Arnoulet C., Durrieu F., Lenormand B., et al. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica 93 (2008) 215-223
29. Mainou-Fowler T., Dignum H., Taylor P.R., Dickinson A.M., Saunders P.W., Proctor S.J., et al. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia. Br J Haematol 118 (2002) 755-761
30. Hsi E.D., Kopecky K.J., Appelbaum F.R., Boldt D., Frey T., Loftus M., et al. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia. Br J Haematol 120 (2003) 1017-1025